Scott J. Charles, Chief Financial Officer at Aralez Pharmaceuticals Inc. (ARLZ), sold 10,804 shares at $1.25 ($14K) on 2017-07-28, disclosed to the SEC on 2017-07-28.
Scheduled sale ($14k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |